X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (43) 43
hematology (33) 33
index medicus (32) 32
female (17) 17
male (15) 15
aged (13) 13
middle aged (13) 13
deficiency (12) 12
peripheral vascular disease (12) 12
acquired hemophilia (10) 10
autoantibodies (10) 10
factor xiii - immunology (10) 10
acquired hemophilia-a (9) 9
adult (9) 9
diagnosis (9) 9
hemophilia (9) 9
aged, 80 and over (8) 8
acquired coagulation disorders (7) 7
b-subunit (7) 7
factor xiii (7) 7
factor xiii deficiency - complications (7) 7
inhibitor (7) 7
plasma factor-xiii (7) 7
therapy (7) 7
acquired fxiii deficiency (6) 6
autoimmunity (6) 6
blood coagulation factor viii (6) 6
factor xiii deficiency - diagnosis (6) 6
factor xiii deficiency - immunology (6) 6
factor-xiii deficiency (6) 6
hemophilia a - drug therapy (6) 6
medicine & public health (6) 6
thrombosis (6) 6
animals (5) 5
autoimmune diseases - immunology (5) 5
case report (5) 5
factor xiii - therapeutic use (5) 5
fibrin (5) 5
hematology, oncology and palliative medicine (5) 5
management (5) 5
oncology (5) 5
plasma (5) 5
treatment outcome (5) 5
antibodies (4) 4
autoantibodies - blood (4) 4
autoantibodies - immunology (4) 4
autoimmune diseases (4) 4
bleeding disorder (4) 4
blood coagulation (4) 4
blood coagulation disorders - blood (4) 4
child (4) 4
coagulation (4) 4
coagulation factors (4) 4
coagulation-factor-xiii (4) 4
enzyme-linked immunosorbent assay (4) 4
factor xiii - antagonists & inhibitors (4) 4
factor xiii - metabolism (4) 4
factor xiii deficiency (4) 4
factor xiii deficiency - blood (4) 4
factor xiii deficiency - therapy (4) 4
health aspects (4) 4
hemophilia a - blood (4) 4
hemorrhage (4) 4
hemorrhage - blood (4) 4
inhibitors (4) 4
patient (4) 4
reproducibility of results (4) 4
thrombin (4) 4
usage (4) 4
acquired (3) 3
acquired deficiency (3) 3
acquired factor xiii deficiency (3) 3
acquired von willebrand syndrome (3) 3
activation (3) 3
adolescent (3) 3
analysis (3) 3
bethesda assay (3) 3
bleeding diathesis (3) 3
blood coagulation - drug effects (3) 3
blood coagulation disorders - diagnosis (3) 3
blood coagulation factors (3) 3
blood coagulation factors - therapeutic use (3) 3
blood coagulation tests - methods (3) 3
blood diseases (3) 3
cancer (3) 3
care and treatment (3) 3
classification (3) 3
cyclophosphamide - therapeutic use (3) 3
enzymes (3) 3
factor xiii - analysis (3) 3
factor xiii - genetics (3) 3
factor xiii deficiency - drug therapy (3) 3
factor xiii/transglutaminases (3) 3
factor-v-leiden (3) 3
factor-viii (3) 3
fxiii (3) 3
hematoma - etiology (3) 3
hemophilia a - immunology (3) 3
hemorrhage - etiology (3) 3
hemorrhagic disorder (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Haemophilia, ISSN 1351-8216, 07/2012, Volume 18, Issue 4, pp. 618 - 620
Journal Article
HAMOSTASEOLOGIE, ISSN 0720-9355, 11/2015, Volume 35, Issue 4A, pp. S32 - S35
Inherited mild factor XIII deficiency belongs to one of the most underdiagnosed bleeding disorders so far. This is, because most patients do not develop... 
FACTOR-XIII DEFICIENCY | FXIII | inherited FXIII deficiency | F13A1 | F13B | acquired FXIII deficiency | MUTATIONS | IDENTIFICATION | HEMATOLOGY | SUBUNIT
Journal Article
Haemophilia, ISSN 1351-8216, 03/2016, Volume 22, Issue 2, pp. 268 - 275
Introduction In factor XIII A subunit (FXIIIA) deficiency, the development of alloantibodies is extremely rare. Only four reports have been published and the... 
alloantibody | acquired FXIII deficiency | FXIII | bleeding diathesis | inherited FXIII deficiency | Acquired FXIII deficiency | Bleeding diathesis | Inherited FXIII deficiency | Alloantibody | Viral antibodies | Antibodies | Thrombin | Chemical properties | Enzyme-linked immunosorbent assay
Journal Article
Journal Article
06/2010, ISBN 1405169141, 7
This chapter contains sections titled: Introduction Structure/function Molecular genetics Clinical presentation Diagnosis Treatment Prognosis References 
activated FXIII cross‐linking fibrin polymers ‐ low concentrations, clot becoming visible | factor XIII (FXIII), transglutaminase enzyme ‐ discovered as clotting protein in coagulation cascade | FXIII‐A | intracranial hemorrhage risk ‐ increasing morbidity and mortality of patients with FXIII deficiency | acquired FXIII deficiency, in several diseases leading to impaired synthesis | in placenta ‐ role in early pregnancy | FXIII perinatal management ‐ in deficient women, varying according to weeks of gestation | heterogeneity, gamut of molecular variation of FXIII gene | factor XIII deficiency | FXIII, role in hemostasis by catalysing cross‐linking of fibrin and fibrin interaction | plasma factor XIII heterotetramer activation | Factor XIII deficiency | FXIII perinatal management - in deficient women, varying according to weeks of gestation | FXIII-A2, in placenta - role in early pregnancy | Acquired FXIII deficiency, in several diseases leading to impaired synthesis | Heterogeneity, gamut of molecular variation of FXIII gene | FXIII, role in hemostasis by catalysing cross-linking of fibrin and fibrin interaction | Plasma factor XIII heterotetramer activation | Activated FXIII cross-linking fibrin polymers - low concentrations, clot becoming visible | Intracranial hemorrhage risk - increasing morbidity and mortality of patients with FXIII deficiency | Factor XIII (FXIII), transglutaminase enzyme - discovered as clotting protein in coagulation cascade
Book Chapter
AMERICAN JOURNAL OF HEMATOLOGY, ISSN 0361-8609, 01/1995, Volume 48, Issue 1, pp. 34 - 39
We report a new case of severe bleeding diathesis due to an acquired inhibitor of fibrin crosslinking. The patient, an 80-year-old woman, was admitted to the... 
FACTOR XIII | ACTIVATION | STABILIZING FACTOR | CONCENTRATE | SUBSTITUTION THERAPY | FACTOR-XIII DEFICIENCY | PLASMA | THERAPY | ACQUIRED COAGULATION DISORDERS | PATIENT | INHIBITOR | PROTEINS | HEMATOLOGY | SUBUNIT
Journal Article
International Journal of Hematology, ISSN 0925-5710, 12/2012, Volume 96, Issue 6, pp. 781 - 785
Journal Article
Journal Article
by Wang, YZ and Wang, LN and Xi, YM and Li, ZJ
MEDICINE, ISSN 0025-7974, 08/2019, Volume 98, Issue 35, p. e16984
Introduction: Chronic myelogenous leukemia (CML), a clonal disorder of pluripotent stem cell, rarely presents with bleeding in chronic phase due to the... 
MEDICINE, GENERAL & INTERNAL | FACTOR-XIII DEFICIENCY | acquired rare hemorrhage | DISORDERS | chronic myelogenous leukaemia | plasma transfusion therapy | CHRONIC MYELOID-LEUKEMIA | Blood coagulation tests | Usage | Research | Chronic myeloid leukemia | Diagnosis | Blood plasma
Journal Article
Journal Article
American Journal of Hematology, ISSN 0361-8609, 01/1995, Volume 48, Issue 1, pp. 34 - 39
We report a new case of severe bleeding diathesis due to an acquired inhibitor of fibrin crosslinking. The patient, an 80‐year‐old woman, was admitted to the... 
acquired coagulation disorders | substitution therapy | factor XIII
Journal Article